Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate
Artelo Biosciences Earlier Reported Q4 EPS $(0.99) Misses $(0.56) Estimate
Artelo Biosciences早些時候公佈的第四季度每股收益美元（0.99美元）未達到預期（0.56美元）
Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.99) per share which missed the analyst consensus estimate of $(0.56) by 76.79 percent. This is a 16.1 percent increase over losses of $(1.18) per share from the same period last year.
Artelo Biosciences（納斯達克股票代碼：ARTL）公佈的季度虧損爲每股0.99美元，比分析師普遍預期的0.56美元（0.56美元）低76.79％。這比去年同期每股虧損1.18美元（1.18美元）增長了16.1％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。